Abstract
High-risk human papillomavirus (HPV) infection is the most common cause of cervical cancer, but low-risk HPV strains can sometimes also be involved. Although HPV genotyping techniques used in clinical diagnosis cannot detect low-risk HPV, next-generation sequencing (NGS) can detect both types. However, DNA library preparation is complicated and expensive. The aim of this study was to develop a simplified, cost-effective sample preparation procedure for HPV genotyping based on next-generation sequencing (NGS). After DNA extraction, a first round of PCR was performed using modified MY09/11 primers specific for the L1 region of the HPV genome, followed by a second round of PCR to add the indexes and adaptors. Then, the DNA libraries were purified and quantified, and high-throughput sequencing was performed using an Illumina MiSeq platform. The sequencing reads were compared with reference sequences for HPV genotyping. The limit of detection for HPV amplification was 100 copies/µl. Analysis of the correlation of pathological cytology with the HPV genotype in individual clinical samples showed that HPV66 was the most common genotype found in the normal stage, whereas HPV16 was the main genotype found in low-grade squamous intraepithelial lesions, high-grade squamous intraepithelial lesions, and cervical cancer. This NGS method can detect and identify several HPV genotypes with 92% accuracy and 100% reproducibility, and it shows potential as a simplified and cost-effective technique for large-scale HPV genotyping in clinical samples.
Similar content being viewed by others
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Alamian S, Esmaelizad M, Zahraei T, Etemadi A, Mohammadi M, Afshar D, Ghaderi S (2017) A Novel PCR Assay for Detecting Brucella abortus and Brucella melitensis. Osong Public Health Res Perspect 8:65–70
Ambulos NP Jr, Schumaker LM, Mathias TJ, White R, Troyer J, Wells D, Cullen KJ (2016) Next-Generation Sequencing-Based HPV Genotyping Assay Validated in Formalin-Fixed, Paraffin-Embedded Oropharyngeal and Cervical Cancer Specimens. J Biomol techniques: JBT 27:46–52
An HJ, Cho NH, Lee SY, Kim IH, Lee C, Kim SJ, Mun MS, Kim SH, Jeong JK (2003) Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer 97:1672–1680
Anderson LA, O'Rorke MA, Wilson R, Jamison J, Gavin AT (2016) HPV prevalence and type-distribution in cervical cancer and premalignant lesions of the cervix: A population-based study from Northern Ireland. J Med Virol 88:1262–1270
Castle PE, Eaton B, Reid J, Getman D, Dockter J (2015) Comparison of human papillomavirus detection by Aptima HPV and cobas HPV tests in a population of women referred for colposcopy following detection of atypical squamous cells of undetermined significance by Pap cytology. J Clin Microbiol 53:1277–1281
Chen J, Zhang R, Ou X, Yao D, Huang Z, Li L, Sun B (2017) Primers and probe design and precision assessment of the real time RT-PCR assay in Coxsackievirus A10 and enterovirus detection. Data in brief 12:418–422
Choi YD, Jung WW, Nam JH, Choi HS, Park CS (2005) Detection of HPV genotypes in cervical lesions by the HPV DNA Chip and sequencing. Gynecol Oncol 98:369–375
Choi YJ, Park JS (2016) Clinical significance of human papillomavirus genotyping. J gynecologic Oncol 27:e21
Cook DA, Mei W, Smith LW, van Niekerk DJ, Ceballos K, Franco EL, Coldman AJ, Ogilvie GS, Krajden M (2015) Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial. BMC Cancer 15:968
da Fonseca AJ, Galvão RS, Miranda AE, Ferreira LC, Chen Z (2016) Comparison of three human papillomavirus DNA detection methods: Next generation sequencing, multiplex-PCR and nested-PCR followed by Sanger based sequencing. J Med Virol 88:888–894
de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menéndez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andújar M, Castellsagué X, Sánchez GI, Nowakowski AM, Bornstein J, Muñoz N, Bosch FX (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 11:1048–1056
Else EA, Swoyer R, Zhang Y, Taddeo FJ, Bryan JT, Lawson J, Van Hyfte I, Roberts CC (2011) Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with INNO-LiPA HPV genotyping extra assay. J Clin Microbiol 49:1907–1912
Flores-Miramontes MG, Torres-Reyes LA, Alvarado-Ruíz L, Romero-Martínez SA, Ramírez-Rodríguez V, Balderas-Peña LM, Vallejo-Ruíz V, Piña-Sánchez P, Cortés-Gutiérrez EI, Jave-Suárez LF, Aguilar-Lemarroy A (2015) Human papillomavirus genotyping by Linear Array and Next-Generation Sequencing in cervical samples from Western Mexico. Virol J 12:161
Gradíssimo A, Burk RD (2017) Molecular tests potentially improving HPV screening and genotyping for cervical cancer prevention. Expert Rev Mol Diagn 17:379–391
Imsamran W, Chaiwerawattana A, Wiangnon S, Pongnikorn D, Suwanrungrung K, Sangrajrang S, Buasom R (2015) Cancer in Thailand vol. VIII, 2010–2012. National Cancer Institute, Thailand
Lindemann ML, Dominguez MJ, de Antonio JC, Sandri MT, Tricca A, Sideri M, Khiri H, Ravet S, Boyle S, Aldrich C, Halfon P (2012) Analytical comparison of the cobas HPV Test with Hybrid Capture 2 for the detection of high-risk HPV genotypes. J Mol diagnostics: JMD 14:65–70
Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM (1989) Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7:209–214
Mardis ER (2008) Next-generation DNA sequencing methods. Annu Rev Genom Hum Genet 9:387–402
Meisal R, Rounge TB, Christiansen IK, Eieland AK, Worren MM, Molden TF, Kommedal Ø, Hovig E, Leegaard TM, Ambur OH (2017) HPV Genotyping of Modified General Primer-Amplicons Is More Analytically Sensitive and Specific by Sequencing than by Hybridization. PLoS ONE 12:e0169074
Muderris T, Afsar I, Yıldız A, Akpınar Varer C (2019) HPV genotype distribution among women with normal and abnormal cervical cytology in Turkey. Revista Esp de quimioterapia: publicacion oficial de la Sociedad Esp de Quimioterapia 32:516–524
Mwendwa F, Mbae CK, Kinyua J, Mulinge E, Mburugu GN, Njiru ZK (2017) Stem loop-mediated isothermal amplification test: comparative analysis with classical LAMP and PCR in detection of Entamoeba histolytica in Kenya. BMC Res Notes 10:142
Nilyanimit P, Chansaenroj J, Poomipak W, Praianantathavorn K, Payungporn S, Poovorawan Y (2018) Comparison of Four Human Papillomavirus Genotyping Methods: Next-generation Sequencing, INNO-LiPA, Electrochemical DNA Chip, and Nested-PCR. Annals of laboratory medicine 38:139–146
Nowak RG, Ambulos NP, Schumaker LM, Mathias TJ, White RA, Troyer J, Wells D, Charurat ME, Bentzen SM, Cullen KJ (2017) Genotyping of high-risk anal human papillomavirus (HPV): ion torrent-next generation sequencing vs. linear array. Virol J 14:112
Poljak M, Marin IJ, Seme K, Vince A (2002) Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail. J Clin virology: official publication Pan Am Soc Clin Virol 25(Suppl 3):S89–97
Poljak M, Oštrbenk A (2013) The Abbott RealTime High Risk HPV test is a clinically validated human papillomavirus assay for triage in the referral population and use in primary cervical cancer screening in women 30 years and older: a review of validation studies. Acta dermatovenerologica Alpina Pannonica et Adriatica 22:43–47
Salazar KL, Zhou HS, Xu J, Peterson LE, Schwartz MR, Mody DR, Ge Y (2015) Multiple Human Papilloma Virus Infections and Their Impact on the Development of High-Risk Cervical Lesions. Acta Cytol 59:391–398
Silveira FA, Almeida G, Furtado Y, Silva KS, Maldonado P, Cavalcanti S, Carvalho Mda G (2015) HPV DNA genotyping and methylation of gene p16 INK4A in cervical LSIL. Exp Mol Pathol 98:308–311
Singh S, Zhou Q, Yu Y, Xu X, Huang X, Zhao J, Han L, Wang K, Sun J, Li F (2015) Distribution of HPV genotypes in Shanghai women. Int J Clin Exp Pathol 8:11901–11908
Tuna M, Amos CI (2017) Next generation sequencing and its applications in HPV-associated cancers. Oncotarget 8:8877–8889
Wang X, Han S, Li X, Wang X, Wang S, Ma L (2022) Prevalence and distribution of human papillomavirus (HPV) in Luoyang city of Henan province during 2015–2021 and the genetic variability of HPV16 and 52. Virol J 19:37
Youens KE, Hosler GA, Washington PJ, Jenevein EP, Murphy KM (2011) Clinical experience with the Cervista HPV HR assay: correlation of cytology and HPV status from 56,501 specimens. J Mol diagnostics: JMD 13:160–166
Youssef MA, Abdelsalam L, Harfoush RA, Talaat IM, Elkattan E, Mohey A, Abdella RM, Farhan MS, Foad HA, Elsayed AM, Elkinaai NA, Ghaith D, Rashed ME, Ghafar MA, Khamis Y, Hosni AN (2016) Prevalence of human papilloma virus (HPV) and its genotypes in cervical specimens of Egyptian women by linear array HPV genotyping test. Infect agents cancer 11:6
Funding
This research was funded by the Thailand Science Research and Innovation Fund (TSRI) (grant number CU_FRB65_hea (27)_034_30_15), a scholarship from the Graduate School, Chulalongkorn University to commemorate the 72nd Anniversary of his Majesty King Bhumibol Adulyadej.
Author information
Authors and Affiliations
Contributions
SP contributed to the study’s conception and design. Material preparation and data collection were performed by UT. Sample collection and laboratory screening were supported by PN. The experiments were carried out by UT, KK, WP, and KP. Data analysis and evaluation were performed by RJ, VS, and SP. The first draft of the manuscript was written by RJ and UT. The tables and figures were prepared by RJ and VS. The manuscript was revised by RJ and SP. YP supervised the study and provided samples. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no potential conflicts of interest.
Ethical approval
This study was approved by the Institutional Review Board of the Faculty of Medicine Chulalongkorn University (IRB number 603/2558).
Additional information
Communicated by Graciela Andrei
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
Below is the link to the electronic supplementary material
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Jitvaropas, R., Thongpoom, U., Sawaswong, V. et al. Development of a simplified and cost-effective sample preparation method for genotyping of human papillomavirus by next-generation sequencing. Arch Virol 168, 185 (2023). https://doi.org/10.1007/s00705-023-05810-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00705-023-05810-w